Почетна › Рак дојке › Kalifornija › Torrance

Kliničke studije za Рак дојке u gradu Torrance, CA

11 studija za Рак дојке traži učesnike na lokacijama u gradu Torrance i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes

Тражи се учесникФаза 2

The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Cente, Torrance

Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07748208

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

Тражи се учесникФаза 3

City of Hope South Bay, Torrance

Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03418961

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Тражи се учесникФаза 3

Torrance Memorial Physician Network - Cancer Care, Torrance

Узраст од 18 до 60 · Жене · Ажурирано 4. 11. 2026. · NCT05879926

Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer

Тражи се учесникФаза 2

City of Hope at South Bay, Torrance

Узраст 40 и старији · Жене · Ажурирано 30. 10. 2026. · NCT06954831

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

Тражи се учесникОпсервациона студија

Harbor-UCLA Medical Center - Hematology / Oncology, Torrance

Узраст 18 и старији · Оба пола · Ажурирано 27. 10. 2026. · NCT06401421

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Тражи се учесникФаза 3

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance
Torrance Memorial Physician Network - Cancer Care, Torrance
Torrance Memorial Physician Network-Cancer Care, Torrance
и још 1

Узраст 18 и старији · Оба пола · Ажурирано 19. 10. 2026. · NCT07062965

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Тражи се учесникФаза 3

Cancer Care Associates, Redondo Beach · 3 ми удаљено

Узраст 18 и старији · Оба пола · Ажурирано 9. 10. 2026. · NCT06757634

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

Тражи се учесникФаза 3

Torrance Memorial Cancer Center, Torrance

Узраст 18 и старији · Оба пола · Ажурирано 2. 9. 2026. · NCT06072612

Tart Cherry and Omega-3's for Aromatase Inhibitor Musculoskeletal Symptoms

Тражи се учесникРана фаза 1

CS Cancer at the Hunt Cancer Center, Torrance

Узраст 18 и старији · Жене · Ажурирано 4. 8. 2026. · NCT06123286

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Тражи се учесникФаза 3

Torrance Memorial Physician Network - Cancer Care, Torrance

Узраст од 50 до 70 · Оба пола · Ажурирано 23. 4. 2026. · NCT04852887

Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer

Тражи се учесникФаза 2

Torrance Memorial Physician Network / Cancer Care, Torrance

Узраст 18 и старији · Оба пола · Ажурирано 10. 11. 2025. · NCT04553770

Studije za Рак дојке u drugim gradovima

Ostale studije u gradu Torrance

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.